Cary Street Partners Investment Advisory’s VanEck Pharmaceutical ETF PPH Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-748	Closed	-$59.7K	–	1498
2023 Q3	$59.7K	Buy	+748	New	+$60.3K	﹤0.01%	819

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Cary Street Partners Investment Advisory's PPH Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2023, closing a stake of 748 shares — an estimated $59.7K sold.

Cary Street Partners Investment Advisory first reported a position in PPH in Q3 2023 and held it in 1 quarter. The position peaked at $59.7K in Q3 2023. 110 funds tracked by Wall St. Rank hold PPH as of Q4 2023.

Cary Street Partners Investment Advisory reported no remaining VanEck Pharmaceutical ETF position as of Q4 2023 after selling out during the quarter.
Cary Street Partners Investment Advisory sold 748 VanEck Pharmaceutical ETF shares in Q4 2023, an estimated $59.7K.
Cary Street Partners Investment Advisory first reported a position in VanEck Pharmaceutical ETF in Q3 2023 and held it in 1 quarter.
Cary Street Partners Investment Advisory's VanEck Pharmaceutical ETF position peaked at $59.7K in Q3 2023.
110 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.